End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.51 CNY | -0.91% | -7.60% | -2.45% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- The company sustains low margins.
- With an expected P/E ratio at 51.5 and 15.77 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.45% | 1.34B | - | ||
+6.11% | 105B | A- | ||
-4.67% | 63.83B | A- | ||
+73.81% | 45.28B | B | ||
+15.46% | 38.93B | B | ||
+5.30% | 33.06B | A- | ||
+11.58% | 20.21B | B- | ||
+13.74% | 16.94B | C+ | ||
+20.05% | 16.08B | B- | ||
+5.02% | 14.49B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 600955 Stock
- Ratings Lihuayi Weiyuan Chemical Co., Ltd.